TCL Archive Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers April 25, 1980
TCL Archive OMB Caused The Problem But Did Not Order Transfer Of $20 Million From Centers Program to Grants Poll April 29, 1983
TCL Archive FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment. July 27, 2001
TCL Archive Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models November 20, 1998
